Details of the SBP
| General Information of Synthetic Binding Protein (SBP) (ID: SBP003536) | ||||||
|---|---|---|---|---|---|---|
| SBP Name |
vNAR anti-SARS-CoV-2 SP240
|
|||||
| Synonyms |
vNAR SP240
|
|||||
| Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
| Expression System | Escherichia coli BL21 (DE3) | |||||
| Selection Method | phage display | |||||
| Highest Status | Research | |||||
| Protein Scaffold Information of This SBP | ||||||
|---|---|---|---|---|---|---|
| Scaffold ID | PS065 | [1] | ||||
| Scaffold Name | vNAR | |||||
| Scaffold Class | Antibody fragment | |||||
| Fold Type | Beta-Sheets + Loops | |||||
| Binding Target(s) of This SBP (BTS) |
|---|
| BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
|---|---|---|---|---|---|---|
| Spike glycoprotein | Neutralizer | SARS-CoV-2 [ICD-11: XN109] | N.A. | Centro de Investigacin Cientfica y Educacin Superior de Ensenada, (CICESE) | [1] | |